Philip Brainin

Philip Brainin, MD PhD MBA is an accomplished professional in the medical and investment sectors, currently serving as an Associate at Sound Bioventures since December 2022, where contributions include leading and supporting investments in companies such as Teitur Trophics and NephroDI. Philip has held significant roles as a Board Observer for Arthex, VarmX, and NephroDI. An Analyst at YVC Collective since February 2024, Philip also serves as a Board Member for Region Hovedstaden and fulfills ad hoc on-call shifts as a physician. Prior experience encompasses an internship at Sunstone Life Science Ventures, a postdoctoral fellowship where Philip founded The Malaria Heart Study, residency in cardiology at Region Hovedstaden, and research fellowships at Herlev og Gentofte Hospital and Harvard Medical School. Academic qualifications include an MBA from Copenhagen Business School, a PhD in Medicine, and an MD, all from the University of Copenhagen.